|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.403
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.402
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.360
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.256
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.256
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.229
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.226
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.217
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.210
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.202
|
|
|
|
positive regulation of rhodopsin gene expression
|
GO:0045872 |
2 |
0.192
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.191
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.162
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.159
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.155
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.155
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.153
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.145
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.144
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.132
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.127
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.124
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.121
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.120
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.120
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.111
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.107
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.107
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.105
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity involved in g2 m transition of mitotic cell cycle
|
GO:0031660 |
1 |
0.101
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.100
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.099
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.098
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.094
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.094
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.093
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.092
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.088
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.088
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.087
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.087
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.085
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.084
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.082
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.078
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.077
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.075
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.075
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.074
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.072
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.071
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.069
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.069
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.069
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.069
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.067
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.066
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.066
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.065
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.065
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.064
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.063
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.063
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.062
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.060
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.060
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.060
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.060
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.060
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.060
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.059
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.057
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.057
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.056
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.054
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.054
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.054
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.054
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.054
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.053
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.052
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.052
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.052
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.052
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.051
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.051
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.051
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.051
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.050
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.050
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.050
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.049
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.049
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.048
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.048
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.048
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.048
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.047
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.047
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.046
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.046
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.046
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.045
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.045
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.045
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.045
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.045
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.045
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.045
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.044
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.043
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.043
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.042
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.042
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.042
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.042
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.041
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.041
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.041
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.041
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.040
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.040
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.040
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.040
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.040
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.039
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.039
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.039
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.038
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.038
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.038
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.038
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.038
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.038
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.038
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.038
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.038
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.037
|
|
|
|
activation of mapkk activity
|
GO:0000186 |
15 |
0.037
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.037
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.036
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.036
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.036
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.036
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.036
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.035
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.035
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.035
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.035
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.035
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.035
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.035
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.035
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.034
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.034
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.034
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.034
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.034
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.033
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.033
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.033
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.033
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.033
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.033
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.032
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.032
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.032
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.032
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.032
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.032
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.031
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.031
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.031
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.031
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.031
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.031
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.031
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.031
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.031
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.031
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.031
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.030
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.030
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.030
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.030
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.030
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.030
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.030
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.030
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.029
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.029
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.029
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.029
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.029
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.029
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.029
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.029
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.029
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.028
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.028
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.028
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.028
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.028
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.028
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.028
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.028
|
|
|
|
substrate dependent cell migration cell attachment to substrate
|
GO:0006931 |
2 |
0.028
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.027
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.027
|
|
|
|
positive regulation of transcription from rna polymerase i promoter
|
GO:0045943 |
3 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.027
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.027
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.027
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.027
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.027
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.027
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.026
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.026
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.026
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.026
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.026
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.026
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.026
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.025
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.025
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.025
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.025
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.025
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.025
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.025
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.025
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.025
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.025
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.025
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.025
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.025
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.025
|
|
|
|
positive regulation of p38mapk cascade
|
GO:1900745 |
1 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.024
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.024
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.024
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.024
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.024
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.024
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.024
|
|
|
|
regulation of rhodopsin gene expression
|
GO:0007468 |
3 |
0.024
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.024
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.024
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.023
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.023
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.023
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.023
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.023
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.023
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.023
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.023
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.022
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.022
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.022
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.022
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.022
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.022
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.022
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.022
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.021
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.021
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.021
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.021
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.021
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.021
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.020
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.020
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.020
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.020
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.020
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.020
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.020
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.020
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.020
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.020
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.020
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.020
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.020
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.020
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.020
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.019
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.019
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.019
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.019
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.019
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
22 |
0.019
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.019
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.019
|
|
|
|
embryonic process involved in female pregnancy
|
GO:0060136 |
7 |
0.019
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.019
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.019
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.019
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.019
|
|
|
|
negative regulation of respiratory burst involved in inflammatory response
|
GO:0060266 |
1 |
0.019
|
|
|
|
regulation of respiratory burst involved in inflammatory response
|
GO:0060264 |
2 |
0.019
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.019
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.018
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.018
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.018
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.018
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.018
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.018
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.018
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.018
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.018
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.018
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.017
|
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
11 |
0.017
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.017
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.017
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.017
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.017
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.017
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.017
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.017
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.017
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.017
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.017
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.017
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.017
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.017
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.017
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.016
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.016
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.016
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.016
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.016
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.016
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.016
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.016
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.016
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.016
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.016
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.016
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.016
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.016
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.016
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.015
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.015
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.015
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0097201 |
1 |
0.015
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.015
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.015
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.015
|
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.015
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.015
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.015
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.015
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.015
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.015
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.015
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.015
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.015
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.015
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.015
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.015
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.015
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.015
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.015
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.015
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.015
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.015
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.014
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.014
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.014
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.014
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.014
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.014
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.014
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.014
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.014
|
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.014
|
|
|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.014
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.014
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
14 |
0.014
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.014
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.014
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.014
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.014
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.014
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.014
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.014
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.014
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.014
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.014
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.014
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.014
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.014
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.013
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.013
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.013
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.013
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.013
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.013
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.013
|
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.013
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.013
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.013
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.013
|
|
